Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · Real-Time Price · USD
30.90
+0.51 (1.68%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Astrana Health Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Astrana Health stock have an average target of 53.29, with a low estimate of 36 and a high estimate of 70. The average target predicts an increase of 72.46% from the current stock price of 30.90.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Astrana Health stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Initiates $36 | Hold | Initiates | $36 | +16.50% | Apr 1, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $50 → $46 | Strong Buy | Maintains | $50 → $46 | +48.87% | Mar 18, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $55 → $49 | Strong Buy | Maintains | $55 → $49 | +58.58% | Mar 4, 2025 |
| Baird | Baird | Buy Maintains $86 → $50 | Buy | Maintains | $86 → $50 | +61.81% | Mar 3, 2025 |
| Stifel | Stifel | Strong Buy Maintains $70 → $56 | Strong Buy | Maintains | $70 → $56 | +81.23% | Feb 20, 2025 |
Financial Forecast
Revenue This Year
2.77B
from 2.03B
Increased by 36.05%
Revenue Next Year
3.38B
from 2.77B
Increased by 21.97%
EPS This Year
1.35
from 0.90
Increased by 49.52%
EPS Next Year
1.78
from 1.35
Increased by 32.22%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.4B | 4.2B | 4.9B | ||
| Avg | 2.8B | 3.4B | 4.0B | ||
| Low | 2.5B | 2.8B | 3.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 64.9% | 53.5% | 44.2% | ||
| Avg | 36.1% | 22.0% | 19.7% | ||
| Low | 21.8% | -0.2% | -1.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.96 | 2.71 | 3.80 |
| Avg | 1.35 | 1.78 | 2.55 |
| Low | 0.85 | 0.41 | 1.00 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 118.3% | 101.6% | 113.4% |
| Avg | 49.5% | 32.2% | 43.3% |
| Low | -5.3% | -69.4% | -43.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.